Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerty Schreibelt

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Expert Review of Clinical Immunology|April 25, 2014
Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapyGhaith Bakdash, Inge Schreurs, Gerty Schreibelt, et al.
Biomedicines|May 25, 2017
Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell MaturationSimone P Sittig, I Jolanda M de Vries, Gerty Schreibelt
Biochimica Et Biophysica Acta|July 6, 2010
Radical changes in multiple sclerosis pathogenesisJack van Horssen, Maarten E Witte, Gerty Schreibelt, et al.
Human Vaccines & Immunotherapeutics|June 21, 2016
Dendritic cell vaccination in melanoma patients: From promising results to future perspectivesSteve Boudewijns, Martine Bloemendal, Winald R Gerritsen, et al.
Frontiers in Immunology|May 1, 2014
Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC SubsetsFlorian Wimmers, Gerty Schreibelt, Annette E Sköld, et al.
Frontiers in Immunology|July 5, 2018
Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOGChristina Wefers, Gerty Schreibelt, Leon F A G Massuger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
Dendritic Cell-Based Immunotherapy: State of the Art and BeyondKalijn F Bol, Gerty Schreibelt, Winald R Gerritsen, et al.
Cancer Letters|June 25, 2017
Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndromeHarm Westdorp, Sigrid Kolders, Nicoline Hoogerbrugge, et al.
Frontiers in Immunology|March 8, 2021
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle CancerJohanna Bödder, Tasmin Zahan, Rianne van Slooten, et al.
Brain Research Reviews|September 1, 2007
Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathologyGerty Schreibelt, Jack van Horssen, Saskia van Rossum, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Expert Review of Clinical Immunology|April 25, 2014
Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapyGhaith Bakdash, Inge Schreurs, Gerty Schreibelt, et al.
Biomedicines|May 25, 2017
Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell MaturationSimone P Sittig, I Jolanda M de Vries, Gerty Schreibelt
Biochimica Et Biophysica Acta|July 6, 2010
Radical changes in multiple sclerosis pathogenesisJack van Horssen, Maarten E Witte, Gerty Schreibelt, et al.
Human Vaccines & Immunotherapeutics|June 21, 2016
Dendritic cell vaccination in melanoma patients: From promising results to future perspectivesSteve Boudewijns, Martine Bloemendal, Winald R Gerritsen, et al.
Frontiers in Immunology|May 1, 2014
Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC SubsetsFlorian Wimmers, Gerty Schreibelt, Annette E Sköld, et al.
Frontiers in Immunology|July 5, 2018
Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOGChristina Wefers, Gerty Schreibelt, Leon F A G Massuger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
Dendritic Cell-Based Immunotherapy: State of the Art and BeyondKalijn F Bol, Gerty Schreibelt, Winald R Gerritsen, et al.
Cancer Letters|June 25, 2017
Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndromeHarm Westdorp, Sigrid Kolders, Nicoline Hoogerbrugge, et al.
Frontiers in Immunology|March 8, 2021
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle CancerJohanna Bödder, Tasmin Zahan, Rianne van Slooten, et al.
Brain Research Reviews|September 1, 2007
Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathologyGerty Schreibelt, Jack van Horssen, Saskia van Rossum, et al.
Pageof 8